{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:40:48Z","timestamp":1659832848141},"reference-count":53,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2017.5483","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T08:19:58Z","timestamp":1510301998000},"source":"Crossref","is-referenced-by-count":0,"title":["Venom based neural modulators (review)"],"prefix":"10.3892","author":[{"given":"Jiao","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pediatric Internal Medicine, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Internal Medicine, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Internal Medicine, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221002, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"key20200713143234_b1-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fnbeh.2016.00244","article-title":"Attenuation of compulsive-like behavior through positive allosteric modulation of \u03b14\u03b22 nicotinic acetylcholine receptors in non-induced compulsive-like mice","volume":"10","author":"Mitra","year":"2017","journal-title":"Front Behav Neurosci"},{"key":"key20200713143234_b2-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biopsych.2010.07.004","article-title":"Effects of an \u03b1 7-nicotinic agonist on default network activity in schizophrenia","volume":"69","author":"Tregellas","year":"2011","journal-title":"Biol Psychiatry"},{"key":"key20200713143234_b3-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00213-016-4514-4","article-title":"The contribution of \u03b14\u03b22 and non-\u03b14\u03b22 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice","volume":"234","author":"de Moura","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"key20200713143234_b4-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nrd3405","article-title":"The productivity crisis in pharmaceutical R&D","volume":"10","author":"Pammolli","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"key20200713143234_b5-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.bcp.2007.05.023","article-title":"Heterogeneity and complexity of native brain nicotinic receptors","volume":"74","author":"Gotti","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"key20200713143234_b6-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.bcp.2011.06.026","article-title":"Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior","volume":"82","author":"Tuesta","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key20200713143234_b7-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tips.2014.11.003","article-title":"Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: Pharmacological tools and endogenous modulators","volume":"36","author":"Tsetlin","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"key20200713143234_b8-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.4155\/fmc.14.102","article-title":"The future of venoms-based drug discovery: An interview with Glenn King","volume":"6","author":"King","year":"2014","journal-title":"Future Med Chem"},{"key":"key20200713143234_b9-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.peptides.2012.04.023","article-title":"Identification of a new specific Kv1.3 channel blocker, Ctri9577, from the scorpion Chaerilus tricostatus","volume":"36","author":"Xie","year":"2012","journal-title":"Peptides"},{"key":"key20200713143234_b10-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.2174\/138161282210160304112133","article-title":"Targeting the nicotinic acetylcholine receptors (nAChRs) in astrocytes as a potential therapeutic target in Parkinsons disease","volume":"22","author":"Jurado-Coronel","year":"2016","journal-title":"Curr Pharm Des"},{"key":"key20200713143234_b11-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1753-4887.2009.00246.x","article-title":"Choline: An essential nutrient for public health","volume":"67","author":"Zeisel","year":"2009","journal-title":"Nutr Rev"},{"key":"key20200713143234_b12-etm-0-0-5483","first-page":"CD000269","article-title":"Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly","volume":"2","author":"Fioravanti","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713143234_b13-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pbb.2015.02.004","article-title":"Neurocognitive effects of acute choline supplementation in low, medium and high performer","volume":"131","author":"Knott","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"key20200713143234_b14-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1523\/JNEUROSCI.3528-14.2015","article-title":"Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus","volume":"35","author":"Xiao","year":"2015","journal-title":"J Neurosci"},{"key":"key20200713143234_b15-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/bs.irn.2015.08.002","article-title":"Nicotinic cholinergic mechanisms in Alzheimers disease","volume":"124","author":"Shen","year":"2015","journal-title":"Int Rev Neurobiol"},{"key":"key20200713143234_b16-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11886-015-0614-8","article-title":"PET imaging of the human nicotinic cholinergic pathway in atherosclerosis","volume":"17","author":"Bauwens","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"key20200713143234_b17-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","article-title":"Cholinergic dysfunction in Parkinsons disease","volume":"13","author":"M\u00fcller","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key20200713143234_b18-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1474-4422(03)00351-X","article-title":"Dementia associated with Parkinsons disease","volume":"2","author":"Emre","year":"2003","journal-title":"Lancet Neurol"},{"key":"key20200713143234_b19-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-319-13665-3_6","article-title":"Nicotinic receptors, memory, and hippocampus","volume":"23","author":"Kutlu","year":"2015","journal-title":"Curr Top Behav Neurosci"},{"key":"key20200713143234_b20-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/en.2006-0907","article-title":"Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of alpha7 nicotinic receptors in isolated rat aortic smooth muscle cells","volume":"148","author":"Wada","year":"2007","journal-title":"Endocrinology"},{"key":"key20200713143234_b21-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbrc.2011.12.127","article-title":"Nicotine-mediated induction of E-selectin in aortic endothelial cells requires Src kinase and E2F1 transcriptional activity","volume":"418","author":"Alamanda","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713143234_b22-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2014.10.150","article-title":"Varenicline aggravates plaque formation through \u03b17 nicotinic acetylcholine receptors in ApoE KO mice","volume":"455","author":"Koga","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713143234_b23-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","article-title":"Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation","volume":"28","author":"Rollema","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"key20200713143234_b24-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key20200713143234_b25-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/npp.2012.20","article-title":"A single administration of low-dose varenicline saturates \u03b14\u03b22* nicotinic acetylcholine receptors in the human brain","volume":"37","author":"Lotfipour","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"key20200713143234_b26-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","article-title":"Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation","volume":"28","author":"Rollema","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"key20200713143234_b27-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/01.crd.0000260270.12829.45","article-title":"Varenicline: A selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation","volume":"15","author":"Lam","year":"2007","journal-title":"Cardiol Rev"},{"key":"key20200713143234_b28-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.ento.51.110104.151146","article-title":"Botanical insecticides, deterrents, and repellents in modern agriculture and an increasingly regulated world","volume":"51","author":"Isman","year":"2006","journal-title":"Annu Rev Entomol"},{"key":"key20200713143234_b29-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1471-4159.2006.04084.x","article-title":"Neonicotinoid insecticides display partial and super agonist actions on native insect nicotinic acetylcholine receptors","volume":"99","author":"Brown","year":"2006","journal-title":"J Neurochem"},{"key":"key20200713143234_b30-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ps.957","article-title":"Experimental study on the toxicity of imidacloprid given in syrup to honey bee (Apis mellifera) colonies","volume":"61","author":"Faucon","year":"2005","journal-title":"Pest Manag Sci"},{"key":"key20200713143234_b31-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.109.055186","article-title":"Diverse actions and target-site selectivity of neonicotinoids: Structural insights","volume":"76","author":"Matsuda","year":"2009","journal-title":"Mol Pharmacol"},{"key":"key20200713143234_b32-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuropharm.2015.01.001","article-title":"Snake neurotoxin \u03b1-bungarotoxin is an antagonist at native GABA(A) receptors","volume":"93","author":"Hannan","year":"2015","journal-title":"Neuropharmacology"},{"key":"key20200713143234_b33-etm-0-0-5483","doi-asserted-by":"crossref","unstructured":"GershoniJMExpression of the \u03b1-bungarotoxin binding site of the nicotinic acetylcholine receptor by Escherichia coli transformantsProc Natl Acad Sci USA8443184321198710.1073\/pnas.84.12.43183295881","DOI":"10.1073\/pnas.84.12.4318"},{"key":"key20200713143234_b34-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.str.2012.05.003","article-title":"Structure and pharmacology of pentameric receptor channels: From bacteria to brain","volume":"20","author":"Corringer","year":"2012","journal-title":"Structure"},{"key":"key20200713143234_b35-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11886-015-0614-8","article-title":"PET imaging of the human nicotinic cholinergic pathway in atherosclerosis","volume":"17","author":"Bauwens","year":"2015","journal-title":"Curr Cardiol Rep"},{"key":"key20200713143234_b36-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.2967\/jnumed.112.108001","article-title":"PET imaging of high-affinity \u03b14\u03b22 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics","volume":"54","author":"Wong","year":"2013","journal-title":"J Nucl Med"},{"key":"key20200713143234_b37-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","article-title":"Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation","volume":"28","author":"Rollema","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"key20200713143234_b38-etm-0-0-5483","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1096\/fj.02-0492fje","article-title":"2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans","volume":"17","author":"Kimes","year":"2003","journal-title":"FASEB J"},{"key":"key20200713143234_b39-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/JGP.0b013e3181b972aa","article-title":"Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimers disease and dementia with Lewy bodies","volume":"18","author":"Colloby","year":"2010","journal-title":"Am J Geriatr Psychiatry"},{"key":"key20200713143234_b40-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"e0133327","DOI":"10.1371\/journal.pone.0133327","article-title":"Nicotinic \u03b14 receptor-mediated cholinergic influences on food intake and activity patterns in hypothalamic circuits","volume":"10","author":"Garc\u00eda","year":"2015","journal-title":"PLoS One"},{"key":"key20200713143234_b41-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3390\/md12052970","article-title":"Conotoxins targeting nicotinic acetylcholine receptors: An overview","volume":"12","author":"Lebbe","year":"2014","journal-title":"Mar Drugs"},{"key":"key20200713143234_b42-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1124\/pr.111.005322","article-title":"Conus venom peptide pharmacology","volume":"64","author":"Lewis","year":"2012","journal-title":"Pharmacol Rev"},{"key":"key20200713143234_b43-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.3390\/md13063259","article-title":"Structural and functional characterization of a novel \u03b1-conotoxin Mr1.7 from Conus marmoreus targeting neuronal nAChR \u03b13\u03b22, \u03b19\u03b110 and \u03b16\/\u03b13\u03b22\u03b23 subtypes","volume":"13","author":"Wang","year":"2015","journal-title":"Mar Drugs"},{"key":"key20200713143234_b44-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1038\/sj.emboj.7601785","article-title":"AChBP-targeted \u03b1-conotoxin correlates distinct binding orientations with nAChR subtype selectivity","volume":"26","author":"Dutertre","year":"2007","journal-title":"EMBO J"},{"key":"key20200713143234_b45-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jmr.683","article-title":"Determination of \u03b1-conotoxin binding modes on neuronal nicotinic acetylcholine receptors","volume":"17","author":"Dutertre","year":"2004","journal-title":"J Mol Recognit"},{"key":"key20200713143234_b46-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4331\/wjbc.v6.i2.28","article-title":"Animal venom studies: Current benefits and future developments","volume":"6","author":"Utkin","year":"2015","journal-title":"World J Biol Chem"},{"key":"key20200713143234_b47-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"281","DOI":"10.6026\/97320630010281","article-title":"A comparative in silico characterization of functional and physicochemical properties of 3FTx (three finger toxin) proteins from four venomous snakes","volume":"10","author":"Roly","year":"2014","journal-title":"Bioinformation"},{"key":"key20200713143234_b48-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3390\/toxins5112172","article-title":"Three-fingered RAVERs: Rapid accumulation of variations in exposed residues of snake venom toxins","volume":"5","author":"Sunagar","year":"2013","journal-title":"Toxins (Basel)"},{"key":"key20200713143234_b49-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tips.2014.11.003","article-title":"Three-finger snake neurotoxins and Ly6 proteins targeting nicotinic acetylcholine receptors: Pharmacological tools and endogenous modulators","volume":"36","author":"Tsetlin","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"key20200713143234_b50-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1039\/B603083C","article-title":"Spider venoms: A rich source of acylpolyamines and peptides as new leads for CNS drugs","volume":"24","author":"Estrada","year":"2007","journal-title":"Nat Prod Rep"},{"key":"key20200713143234_b51-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"11296","DOI":"10.1002\/anie.201101599","article-title":"Small molecules from spiders used as chemical probes","volume":"50","author":"Olsen","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"key":"key20200713143234_b52-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.toxicon.2004.11.013","article-title":"Polyamine toxins: Development of selective ligands for ionotropic receptors","volume":"45","author":"Str\u00f8mgaard","year":"2005","journal-title":"Toxicon"},{"key":"key20200713143234_b53-etm-0-0-5483","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.toxicon.2013.04.020","article-title":"VdTX-1, a reversible nicotinic receptor antagonist isolated from venom of the spider Vitalius dubius (Theraphosidae)","volume":"70","author":"Rocha-E-Silva","year":"2013","journal-title":"Toxicon"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T00:02:45Z","timestamp":1659830565000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.5483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":53,"URL":"https:\/\/doi.org\/10.3892\/etm.2017.5483","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]}}}